ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

AstraZeneca has pact with Naeja

March 20, 2006 | APPEARED IN VOLUME 84, ISSUE 12

The contract chemistry research company Naeja Pharmaceutical will receive $10.2 million from AstraZeneca Canada under a three-year research partnership focused on accelerating the development of novel pain-control compounds. Naeja, based in Edmonton, Alberta, says it will work with chemists at AstraZeneca's Montreal drug discovery center in preclinical discovery and development. Naeja employs more than 100 scientists, 80 of whom hold Ph.D.s; it says the agreement will create 20 new jobs.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment